Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis

PURPOSE: Increased lipoprotein-associated phospholipase A2 (Lp-PLA2) activity and Rho kinase activity may be associated with atherosclerosis. The principal aim of this study was to examine whether darapladib (a selective Lp-PLA2 inhibitor) could reduce the elevated Lp-PLA2 and Rho kinase activity in...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Yonsei Med J
Главные авторы: Zhang, Juan, Xu, Dong-Ling, Liu, Xiao-Bo, Bi, Shao-jie, Zhao, Tong, Sui, Shu-Jian, Ji, Xiao-Ping, Lu, Qing-Hua
Формат: Artigo
Язык:Inglês
Опубликовано: Yonsei University College of Medicine 2016
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4740522/
https://ncbi.nlm.nih.gov/pubmed/26847282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2016.57.2.321
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы